Cargando…
Metronomic Chemotherapy in Pediatric Oncology: From Preclinical Evidence to Clinical Studies
Metronomic chemotherapy (MC) is the frequent, regular administration of drug doses designed to maintain a low, but active, range of concentrations of chemotherapeutic drugs, during prolonged periods of time without inducing excessive toxicities. To date, more than 400,000 children and adolescents un...
Autores principales: | Banchi, Marta, Fini, Elisabetta, Crucitta, Stefania, Bocci, Guido |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9657890/ https://www.ncbi.nlm.nih.gov/pubmed/36362482 http://dx.doi.org/10.3390/jcm11216254 |
Ejemplares similares
-
Metronomic Chemotherapy
por: Cazzaniga, Marina Elena, et al.
Publicado: (2021) -
Metronomic chemotherapy for triple negative breast cancer?
por: Di Desidero, Teresa, et al.
Publicado: (2016) -
Impact of CTLA-4 blockade in conjunction with metronomic chemotherapy on preclinical breast cancer growth
por: Parra, Karla, et al.
Publicado: (2017) -
Metronomic chemotherapy
por: Maiti, Rituparna
Publicado: (2014) -
Metronomic Chemotherapy for Metastatic Breast Cancer Treatment: Clinical and Preclinical Data between Lights and Shadows
por: Cazzaniga, Marina Elena, et al.
Publicado: (2022)